Closely related, yet unique: Distinct homo- and heterodimerization patterns of G protein coupled chemokine receptors and their fine-tuning by cholesterol
暂无分享,去创建一个
Kristyna Pluhackova | Stefan Gahbauer | Rainer A. Böckmann | R. Böckmann | K. Pluhackova | Stefan Gahbauer | Kristyna Pluhackova
[1] H. Attrill,et al. The role of cholesterol on the activity and stability of neurotensin receptor 1. , 2012, Biochimica et biophysica acta.
[2] Jing Huang,et al. CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data , 2013, J. Comput. Chem..
[3] Tracy M Handel,et al. Chemokine: receptor structure, interactions, and antagonism. , 2007, Annual review of immunology.
[4] Marc Parmentier,et al. Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers* , 2007, Journal of Biological Chemistry.
[5] R. Best,et al. Convergence and Sampling in Determining Free Energy Landscapes for Membrane Protein Association , 2016, The journal of physical chemistry. B.
[6] M. Babu,et al. Molecular signatures of G-protein-coupled receptors , 2013, Nature.
[7] D. Tieleman,et al. The MARTINI force field: coarse grained model for biomolecular simulations. , 2007, The journal of physical chemistry. B.
[8] Yasuyuki Kihara,et al. Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1 , 2015, Cell.
[9] M. Parrinello,et al. Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .
[10] Vijay S Pande,et al. Combining molecular dynamics with bayesian analysis to predict and evaluate ligand-binding mutations in influenza hemagglutinin. , 2009, Journal of the American Chemical Society.
[11] C. Martínez-A,et al. Chemokine receptor dimerization: two are better than one. , 2001, Trends in immunology.
[12] Hao Wang,et al. Assessing the Relative Stability of Dimer Interfaces in G Protein-Coupled Receptors , 2012, PLoS Comput. Biol..
[13] C. Martínez-A,et al. Chemokine receptor oligomerization: a further step toward chemokine function. , 2012, Immunology letters.
[14] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[15] C. Martínez-A,et al. HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] Ruben Abagyan,et al. Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists , 2016, Nature.
[17] R. Larson,et al. The MARTINI Coarse-Grained Force Field: Extension to Proteins. , 2008, Journal of chemical theory and computation.
[18] M. Bouvier,et al. Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.
[19] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[20] Siewert J Marrink,et al. Structural determinants of the supramolecular organization of G protein-coupled receptors in bilayers. , 2012, Journal of the American Chemical Society.
[21] Alfonso Valencia,et al. Identification of amino acid residues crucial for chemokine receptor dimerization , 2004, Nature Immunology.
[22] Berk Hess,et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .
[23] M. Parmentier,et al. Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists* , 2009, The Journal of Biological Chemistry.
[24] Graeme Milligan,et al. G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function , 2009, British journal of pharmacology.
[25] Durba Sengupta,et al. Identification of cholesterol binding sites in the serotonin1A receptor. , 2012, The journal of physical chemistry. B.
[26] R. Böckmann,et al. Exploring the Formation and the Structure of Synaptobrevin Oligomers in a Model Membrane. , 2016, Biophysical journal.
[27] M. Parmentier,et al. Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers , 2006, Molecular Pharmacology.
[28] G. Gimpl. Interaction of G protein coupled receptors and cholesterol. , 2016, Chemistry and physics of lipids.
[29] Ji Ming Wang,et al. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion , 2006, Virology Journal.
[30] B. L. de Groot,et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins , 2016, Nature Methods.
[31] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[32] O. Boyman,et al. Inflammation-Induced CCR7 Oligomers Form Scaffolds to Integrate Distinct Signaling Pathways for Efficient Cell Migration. , 2016, Immunity.
[33] Marta Filizola,et al. Differential Stability of the Crystallographic Interfaces of Mu- and Kappa-Opioid Receptors , 2014, PloS one.
[34] C. Martínez-A,et al. Blocking HIV‐1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor , 2004, The EMBO journal.
[35] Mario Mellado,et al. Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.
[36] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[37] S. Rasmussen,et al. The structure and function of G-protein-coupled receptors , 2009, Nature.
[38] Anna L. Duncan,et al. Molecular dynamics simulations of membrane proteins and their interactions: from nanoscale to mesoscale , 2016, Current opinion in structural biology.
[39] D. Selley,et al. Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization. , 2016, Bioorganic & medicinal chemistry.
[40] Hualiang Jiang,et al. Two disparate ligand-binding sites in the human P2Y1 receptor , 2015, Nature.
[41] Davide Provasi,et al. Impact of Lipid Composition and Receptor Conformation on the Spatio-temporal Organization of μ-Opioid Receptors in a Multi-component Plasma Membrane Model , 2016, PLoS Comput. Biol..
[42] Sébastien Boutet,et al. Structure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography , 2015, Cell.
[43] Marc Parmentier,et al. Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. , 2002, Molecular biology of the cell.
[44] Luc Vincent,et al. Watersheds in Digital Spaces: An Efficient Algorithm Based on Immersion Simulations , 1991, IEEE Trans. Pattern Anal. Mach. Intell..
[45] Xavier Periole,et al. Interplay of G Protein-Coupled Receptors with the Membrane: Insights from Supra-Atomic Coarse Grain Molecular Dynamics Simulations. , 2017, Chemical reviews.
[46] M. Parrinello,et al. Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.
[47] M. Norcross,et al. Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy. , 2008, Drug discovery today.
[48] A. Chattopadhyay,et al. Cholesterol modulates the dimer interface of the β₂-adrenergic receptor via cholesterol occupancy sites. , 2014, Biophysical journal.
[49] Yan Zhang,et al. Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies. , 2014, Current topics in medicinal chemistry.
[50] F. Lezoualc’h,et al. Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers. , 2008, Current drug discovery technologies.
[51] F. Ciruela,et al. Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors , 2016, Scientific Reports.
[52] Peter M. Kasson,et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..
[53] Michel Bouvier,et al. Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.
[54] Helgi I. Ingólfsson,et al. Computational Lipidomics with insane: A Versatile Tool for Generating Custom Membranes for Molecular Simulations. , 2015, Journal of chemical theory and computation.
[55] C. Combs,et al. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions , 2006, Molecular Cancer Therapeutics.
[56] M. Norcross,et al. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4 , 2004, Journal of cellular biochemistry.
[57] D. Taub,et al. Inhibition of chemokine receptor function by membrane cholesterol oxidation. , 2003, Experimental cell research.
[58] A. Chattopadhyay,et al. Cholesterol-dependent Conformational Plasticity in GPCR Dimers , 2016, Scientific Reports.
[59] Xavier Periole,et al. Combining an Elastic Network With a Coarse-Grained Molecular Force Field: Structure, Dynamics, and Intermolecular Recognition. , 2009, Journal of chemical theory and computation.
[60] Allen P. Liu,et al. Multiplex Detection of Homo- and Heterodimerization of G Protein-Coupled Receptors by Proximity Biotinylation , 2014, PloS one.
[61] Steven M. Moss,et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug , 2014, Nature.
[62] I. Ulasov,et al. Chemokines in tumor progression and metastasis , 2013, Oncotarget.
[63] Davide Provasi,et al. Making Structural Sense of Dimerization Interfaces of Delta Opioid Receptor Homodimers , 2011, Biochemistry.
[64] I. D. de Esch,et al. Structural Analysis of Chemokine Receptor–Ligand Interactions , 2017, Journal of medicinal chemistry.
[65] Susan R. George,et al. G-Protein-coupled receptor oligomerization and its potential for drug discovery , 2002, Nature Reviews Drug Discovery.
[66] Tsjerk A. Wassenaar,et al. Dynamic Cholesterol-Conditioned Dimerization of the G Protein Coupled Chemokine Receptor Type 4 , 2016, PLoS Comput. Biol..
[67] M. Stone,et al. Mechanisms of Regulation of the Chemokine-Receptor Network , 2017, International journal of molecular sciences.
[68] Davide Provasi,et al. Preferred Supramolecular Organization and Dimer Interfaces of Opioid Receptors from Simulated Self-Association , 2015, PLoS Comput. Biol..
[69] Michel Bouvier,et al. Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.
[70] Ji Ming Wang,et al. Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells , 2002, Journal of Virology.
[71] C. Martínez-A,et al. Chemokine control of HIV-1 infection , 1999, Nature.
[72] Siewert J Marrink,et al. Going Backward: A Flexible Geometric Approach to Reverse Transformation from Coarse Grained to Atomistic Models. , 2014, Journal of chemical theory and computation.
[73] M. Filizola,et al. Lessons from Free Energy Simulations of δ-Opioid Receptor Homodimers Involving the Fourth Transmembrane Helix† , 2010, Biochemistry.
[74] Akihiro Kusumi,et al. Single-molecule imaging revealed dynamic GPCR dimerization. , 2014, Current opinion in cell biology.
[75] George Khelashvili,et al. Membrane Driven Spatial Organization of GPCRs , 2013, Scientific Reports.
[76] Helmut Grubmüller,et al. Determining equilibrium constants for dimerization reactions from molecular dynamics simulations , 2011, J. Comput. Chem..
[77] Hualiang Jiang,et al. Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex , 2013, Science.
[78] Rodrigo Lopez,et al. Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..
[79] L. Prézeau,et al. The chemokine CXC4 and CC2 receptors form homo‐ and heterooligomers that can engage their signaling G‐protein effectors and βarrestin , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[80] M. Oppermann,et al. G Protein-coupled Receptor Kinases Promote Phosphorylation and β-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers* , 2005, Journal of Biological Chemistry.
[81] D. Tieleman,et al. High-Throughput Simulations of Dimer and Trimer Assembly of Membrane Proteins. The DAFT Approach. , 2015, Journal of chemical theory and computation.
[82] A. Wanchu,et al. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics. , 2006, Journal of postgraduate medicine.
[83] M. Thelen,et al. Modulation of Chemokine Receptor Function by Cholesterol: New Prospects for Pharmacological Intervention , 2017, Molecular Pharmacology.
[84] Gregory J Babcock,et al. Ligand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor* , 2003, The Journal of Biological Chemistry.
[85] W F Drew Bennett,et al. Improved Parameters for the Martini Coarse-Grained Protein Force Field. , 2013, Journal of chemical theory and computation.
[86] Aashish Manglik,et al. Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation , 2016, Nature.
[87] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[88] Tullio Pozzan,et al. CXCR4–CCR5: A couple modulating T cell functions , 2008, Proceedings of the National Academy of Sciences.
[89] C. Martínez-A,et al. The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[90] T. Handel,et al. Chemokine receptor oligomerization and allostery. , 2013, Progress in molecular biology and translational science.
[91] W. Messer. Bivalent ligands for G protein-coupled receptors. , 2004, Current pharmaceutical design.
[92] D. Taub,et al. Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. , 2002, Blood.
[93] Alexander D. MacKerell,et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. , 2010, The journal of physical chemistry. B.
[94] Laura Martínez-Muñoz,et al. CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface , 2014, Proceedings of the National Academy of Sciences.
[95] M. Oppermann,et al. Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent. , 2004, Molecular biology of the cell.
[96] P. Stansfeld,et al. Interaction of lipids with the neurotensin receptor 1. , 2016, Biochimica et biophysica acta.
[97] R. Böckmann,et al. Synaptobrevin Transmembrane Domain Dimerization Studied by Multiscale Molecular Dynamics Simulations. , 2015, Biophysical journal.
[98] S. Feller,et al. Rhodopsin exhibits a preference for solvation by polyunsaturated docosohexaenoic acid. , 2003, Journal of the American Chemical Society.
[99] George Hedger,et al. Lipid interaction sites on channels, transporters and receptors: Recent insights from molecular dynamics simulations. , 2016, Biochimica et biophysica acta.
[100] Tomohiro Nishizawa,et al. Activation mechanism of endothelin ETB receptor by endothelin-1 , 2016, Nature.
[101] P. Dijkman,et al. Lipid modulation of early G protein-coupled receptor signalling events. , 2015, Biochimica et biophysica acta.
[102] N. Tarasova,et al. Inhibition of G-protein-coupled Receptor Function by Disruption of Transmembrane Domain Interactions* , 1999, The Journal of Biological Chemistry.
[103] R. Böckmann,et al. Biomembranes in atomistic and coarse-grained simulations , 2015, Journal of physics. Condensed matter : an Institute of Physics journal.
[104] N. Yamamoto,et al. Ligand‐independent higher‐order multimerization of CXCR4, a G‐protein‐coupled chemokine receptor involved in targeted metastasis , 2009, Cancer science.
[105] S. Marullo,et al. On the dimerization of CCR5 , 2005, Nature Immunology.
[106] Shrish Tiwari,et al. Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. , 2011, Biochemical and biophysical research communications.
[107] P. Dijkman,et al. Lipid-dependent GPCR dimerization. , 2013, Methods in cell biology.
[108] Ali Jazayeri,et al. Intracellular allosteric antagonism of the CCR9 receptor , 2016, Nature.
[109] D. Taub,et al. CXCR4 Function Requires Membrane Cholesterol: Implications for HIV Infection , 2002, The Journal of Immunology.
[110] T. Jin,et al. Fluorescence Resonance Energy Transfer Imaging Reveals that Chemokine-Binding Modulates Heterodimers of CXCR4 and CCR5 Receptors , 2008, PloS one.
[111] I. Vattulainen,et al. Excessive aggregation of membrane proteins in the Martini model , 2017, PloS one.
[112] D. Higgins,et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.
[113] Ruben Abagyan,et al. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine , 2015, Science.
[114] T. Jin,et al. HIV gp120-induced Interaction between CD4 and CCR5 Requires Cholesterol-rich Microenvironments Revealed by Live Cell Fluorescence Resonance Energy Transfer Imaging* , 2006, Journal of Biological Chemistry.
[115] P. Toth,et al. Regulation of CXCR4 Receptor Dimerization by the Chemokine SDF-1α and the HIV-1 Coat Protein gp120: A Fluorescence Resonance Energy Transfer (FRET) Study , 2004, Journal of Pharmacology and Experimental Therapeutics.
[116] T. Handel,et al. Modulation of chemokine receptor activity through dimerization and crosstalk , 2009, Cellular and Molecular Life Sciences.
[117] Fang Huang,et al. Single-Molecule Imaging Demonstrates Ligand Regulation of the Oligomeric Status of CXCR4 in Living Cells. , 2017, The journal of physical chemistry. B.
[118] Thomas Huber,et al. G protein-coupled receptors self-assemble in dynamics simulations of model bilayers. , 2007, Journal of the American Chemical Society.
[119] C. Gilon,et al. Backbone cyclic helix mimetic of chemokine (C-C motif) receptor 2: a rational approach for inhibiting dimerization of G protein-coupled receptors. , 2013, Bioorganic & medicinal chemistry.
[120] K. Eidne,et al. Application of G protein-coupled receptor-heteromer identification technology to monitor β-arrestin recruitment to G protein-coupled receptor heteromers. , 2011, Assay and drug development technologies.
[121] M. Parmentier,et al. Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.
[122] A. Mark,et al. Coarse grained model for semiquantitative lipid simulations , 2004 .
[123] D. Müller,et al. Mechanism of allosteric regulation of β2-adrenergic receptor by cholesterol , 2016, eLife.
[124] Rodrigo Lopez,et al. The EMBL-EBI bioinformatics web and programmatic tools framework , 2015, Nucleic Acids Res..
[125] Tsjerk A. Wassenaar,et al. Mixing MARTINI: electrostatic coupling in hybrid atomistic-coarse-grained biomolecular simulations. , 2013, The journal of physical chemistry. B.
[126] A. Proudfoot. Chemokine receptors: multifaceted therapeutic targets , 2002, Nature Reviews Immunology.
[127] Alan Grossfield,et al. A role for direct interactions in the modulation of rhodopsin by ω-3 polyunsaturated lipids , 2006 .